Amiya Eisuke
Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Department of Therapeutic Strategy for Heart Failure, University of Tokyo, Tokyo, Japan.
Front Cardiovasc Med. 2022 Mar 7;9:831918. doi: 10.3389/fcvm.2022.831918. eCollection 2022.
Heart failure (HF) has various characteristics, such as etiology, clinical course, and clinical characteristics. Several studies reported the clinical findings of the characteristics of non-ischemic cardiomyopathy. There have been issues with genetic, biochemical, or pathophysiological problems. Some studies have been conducted on non-ischemic cardiomyopathy and social factors, for instance, racial disparities in peripartum cardiomyopathy (PPCM) or the social setting of hypertrophic cardiomyopathy. However, there have been insufficient materials to consider the relationship between social factors and clinical course in non-ischemic cardiomyopathies. There were various methodologies in therapeutic interventions, such as pharmacological, surgical, or rehabilitational, and educational issues. However, interventions that could be closely associated with social inequality have not been sufficiently elucidated. We will summarize the effects of social equality, which could have a large impact on the development and progression of HF in non-ischemic cardiomyopathies.
心力衰竭（HF）具有多种特征，如病因、临床病程和临床特点。多项研究报告了非缺血性心肌病特征的临床发现。存在遗传、生化或病理生理方面的问题。一些关于非缺血性心肌病与社会因素的研究已经开展，例如围产期心肌病（PPCM）中的种族差异或肥厚型心肌病的社会背景。然而，尚无足够资料来考量非缺血性心肌病中社会因素与临床病程之间的关系。治疗干预存在多种方法，如药物、手术或康复治疗以及教育问题。然而，与社会不平等密切相关的干预措施尚未得到充分阐明。我们将总结社会平等的影响，其可能对非缺血性心肌病中HF的发生和发展产生重大影响。
